Bio-Thera Solutions Ltd
Bio-Thera Solutions, Ltd., a biopharmaceutical company, researches and develops novel therapeutics for the treatment of cancer, autoimmune, cardiovascular, eye diseases, and other severe unmet medical needs in China and internationally. It offers QLETLI for the treatment of ankylosing spondylitis, rheumatoid arthritis, psoriasis, Crohn's disease, and uveitis; POBEVCY to treat patients with metast… Read more
Market Cap & Net Worth: Bio-Thera Solutions Ltd (688177)
Bio-Thera Solutions Ltd (SHG:688177) has a market capitalization of $1.26 Billion (CN¥9.22 Billion) as of March 18, 2026. Listed on the SHG stock exchange, this China-based company holds position #11859 globally and #2861 in its home market, demonstrating a 3.58% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bio-Thera Solutions Ltd's stock price CN¥22.27 by its total outstanding shares 414080000 (414.08 Million).
Bio-Thera Solutions Ltd Market Cap History: 2020 to 2026
Bio-Thera Solutions Ltd's market capitalization history from 2020 to 2026. Data shows change from $1.79 Billion to $1.26 Billion (-15.13% CAGR).
Bio-Thera Solutions Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bio-Thera Solutions Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.47x
Bio-Thera Solutions Ltd's market cap is 1.47 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $1.79 Billion | $184.99 Million | -$513.23 Million | 9.70x | N/A |
| 2021 | $1.46 Billion | $836.58 Million | $81.94 Million | 1.74x | 17.79x |
| 2022 | $1.23 Billion | $455.13 Million | -$480.40 Million | 2.70x | N/A |
| 2023 | $2.33 Billion | $704.79 Million | -$394.53 Million | 3.30x | N/A |
| 2024 | $1.09 Billion | $743.17 Million | -$510.30 Million | 1.47x | N/A |
Competitor Companies of 688177 by Market Capitalization
Companies near Bio-Thera Solutions Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Bio-Thera Solutions Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Bio-Thera Solutions Ltd Historical Marketcap From 2020 to 2026
Between 2020 and today, Bio-Thera Solutions Ltd's market cap moved from $1.79 Billion to $ 1.26 Billion, with a yearly change of -15.13%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.26 Billion | -3.76% |
| 2025 | CN¥1.31 Billion | +19.40% |
| 2024 | CN¥1.09 Billion | -53.01% |
| 2023 | CN¥2.33 Billion | +89.35% |
| 2022 | CN¥1.23 Billion | -15.68% |
| 2021 | CN¥1.46 Billion | -18.77% |
| 2020 | CN¥1.79 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Bio-Thera Solutions Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.26 Billion USD |
| MoneyControl | $1.26 Billion USD |
| MarketWatch | $1.26 Billion USD |
| marketcap.company | $1.26 Billion USD |
| Reuters | $1.26 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.